rs11748431
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs11748431(A;A) |
Make rs11748431(A;G) |
Make rs11748431(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 5 |
Position | 180641741 |
Gene | FLT4 |
is a | snp |
is | mentioned by |
dbSNP | rs11748431 |
dbSNP (classic) | rs11748431 |
ClinGen | rs11748431 |
ebi | rs11748431 |
HLI | rs11748431 |
Exac | rs11748431 |
Gnomad | rs11748431 |
Varsome | rs11748431 |
LitVar | rs11748431 |
Map | rs11748431 |
PheGenI | rs11748431 |
Biobank | rs11748431 |
1000 genomes | rs11748431 |
hgdp | rs11748431 |
ensembl | rs11748431 |
geneview | rs11748431 |
scholar | rs11748431 |
rs11748431 | |
pharmgkb | rs11748431 |
gwascentral | rs11748431 |
openSNP | rs11748431 |
23andMe | rs11748431 |
SNPshot | rs11748431 |
SNPdbe | rs11748431 |
MSV3d | rs11748431 |
GWAS Ctlg | rs11748431 |
GMAF | 0.146 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
[PMID 23232491] A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528